Get the Stockscreener App
24.84
0.22%
0.0644
Overview
News
Price History
Option Chain
Financials
Why PFE Down?
Discussions
Forecast
Stock Split
Dividend History
Pfizer Inc stock is traded at $24.84, with a volume of 31.93M.
It is up +0.22% in the last 24 hours and up +4.04% over the past month.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
See More
Previous Close:
$24.78
Open:
$24.84
24h Volume:
31.93M
Relative Volume:
0.67
Market Cap:
$141.20B
Revenue:
$63.83B
Net Income/Loss:
$10.77B
P/E Ratio:
13.22
EPS:
1.8799
Net Cash Flow:
$12.44B
1W Performance:
-6.03%
1M Performance:
+4.04%
6M Performance:
+13.35%
1Y Performance:
-14.83%
1-Day Range:
$24.61
$24.95
1-Week Range:
$24.61
$26.58
52-Week Range:
$20.91
$29.82
Pfizer Inc Stock (PFE) Company Profile
Name
Pfizer Inc
Sector
Industry
Phone
(212) 733-2323
Address
66 HUDSON BOULEVARD EAST, NEW YORK, NY
Compare PFE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PFE
Pfizer Inc
|
24.84 | 140.89B | 63.83B | 10.77B | 12.44B | 1.8799 |
|
LLY
Lilly Eli Co
|
823.27 | 747.19B | 53.26B | 13.80B | -50.20M | 15.08 |
|
JNJ
Johnson Johnson
|
190.64 | 459.32B | 90.62B | 22.66B | 18.18B | 9.35 |
|
ABBV
Abbvie Inc
|
231.97 | 407.19B | 58.33B | 3.73B | 18.24B | 2.1013 |
|
NVS
Novartis Ag Adr
|
129.81 | 251.72B | 53.40B | 13.68B | 16.89B | 6.8864 |
|
MRK
Merck Co Inc
|
85.66 | 214.78B | 63.43B | 16.42B | 14.72B | 6.4861 |
Pfizer Inc Stock (PFE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-22-25 | Initiated | Cantor Fitzgerald | Neutral |
| Dec-10-24 | Resumed | BofA Securities | Neutral |
| Nov-15-24 | Initiated | Wolfe Research | Underperform |
| Oct-25-24 | Resumed | Citigroup | Neutral |
| Oct-17-24 | Initiated | Bernstein | Mkt Perform |
| Aug-07-24 | Upgrade | Daiwa Securities | Neutral → Outperform |
| Mar-22-24 | Downgrade | Argus | Buy → Hold |
| Feb-23-24 | Initiated | Guggenheim | Buy |
| Jan-04-24 | Downgrade | TD Cowen | Outperform → Market Perform |
| Oct-20-23 | Resumed | UBS | Neutral |
| Oct-16-23 | Upgrade | Jefferies | Hold → Buy |
| Jul-17-23 | Reiterated | JP Morgan | Neutral |
| Jul-14-23 | Initiated | HSBC Securities | Buy |
| Jun-29-23 | Downgrade | Credit Suisse | Outperform → Neutral |
| May-11-23 | Downgrade | Daiwa Securities | Outperform → Neutral |
| Mar-06-23 | Initiated | Jefferies | Hold |
| Feb-07-23 | Upgrade | Daiwa Securities | Neutral → Outperform |
| Jan-26-23 | Downgrade | UBS | Buy → Neutral |
| Jan-17-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-04-23 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-13-22 | Upgrade | Goldman | Neutral → Buy |
| Nov-18-22 | Initiated | Credit Suisse | Outperform |
| May-23-22 | Initiated | SVB Leerink | Mkt Perform |
| Apr-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Jan-05-22 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-03-22 | Reiterated | Bernstein | Mkt Perform |
| Dec-20-21 | Reiterated | Cowen | Outperform |
| Dec-17-21 | Initiated | Goldman | Neutral |
| Dec-13-21 | Upgrade | UBS | Neutral → Buy |
| Dec-09-21 | Initiated | Wells Fargo | Overweight |
| Nov-19-21 | Initiated | BMO Capital Markets | Outperform |
| Jul-27-21 | Resumed | Truist | Buy |
| May-06-21 | Downgrade | Mizuho | Buy → Neutral |
| Apr-07-21 | Resumed | RBC Capital Mkts | Sector Perform |
| Feb-04-21 | Upgrade | DZ Bank | Hold → Buy |
| Dec-16-20 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-19-20 | Resumed | Goldman | Neutral |
| Nov-10-20 | Resumed | Bernstein | Mkt Perform |
| Oct-12-20 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Sep-29-20 | Initiated | Berenberg | Hold |
| Jun-16-20 | Initiated | SVB Leerink | Mkt Perform |
| Feb-27-20 | Initiated | Barclays | Equal Weight |
| Feb-27-20 | Upgrade | Standpoint Research | Hold → Buy |
| Feb-06-20 | Initiated | Mizuho | Buy |
| Jan-07-20 | Initiated | RBC Capital Mkts | Outperform |
| Oct-17-19 | Resumed | BofA/Merrill | Neutral |
| Jul-30-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jul-30-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-04-19 | Resumed | Morgan Stanley | Overweight |
| Feb-20-19 | Resumed | Citigroup | Neutral |
| Jan-31-19 | Upgrade | Argus | Hold → Buy |
| Jan-31-19 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jan-23-19 | Downgrade | UBS | Buy → Neutral |
| Dec-11-18 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-01-18 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
View All
Pfizer Inc Stock (PFE) Latest News
Lawsuits Claim Pfizer Failed to Warn of Brain Tumor Risk From Birth Control Shot - Truthout
Trump Secures Major Win as AstraZeneca Joins Pfizer in Lowering US Drug Prices - Medical Daily
Global markets live: Blackstone, Pfizer, Tesla, Stellantis, AstraZeneca… - MarketScreener
Pfizer stock rises as BMO Capital reiterates Outperform rating - Investing.com
Down 44%, Should You Buy the Dip on Viking Therapeutics? - The Motley Fool
Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know - Yahoo Finance
IP Group shares fly on back of Metsera & Pfizer news - BusinessCloud
Verdence Capital Advisors LLC Increases Stake in Pfizer Inc. $PFE - MarketBeat
Pfizer To Highlight Advancements In Respiratory Health And Infectious Disease Research At IDWeek 2025 - TradingView
Griffin Asset Management Inc. Grows Holdings in Pfizer Inc. $PFE - MarketBeat
Pfizer to present infectious disease data at IDWeek 2025 - Investing.com
Concurrent Investment Advisors LLC Purchases 20,663 Shares of Pfizer Inc. $PFE - MarketBeat
Pfizer to Highlight Advancements in Respiratory Health and Infectious Disease Research at IDWeek 2025 - Business Wire
Vanguard Personalized Indexing Management LLC Grows Position in Pfizer Inc. $PFE - MarketBeat
Estrogen Blockers Market Is Booming Worldwide 2025-2032 | Pfizer Inc., Novartis AG, AstraZeneca PLC - openPR.com
IP Group in line for future royalties from Pfizer’s drug deal - Proactive Investors
FY2025 EPS Estimates for Pfizer Lowered by Cantor Fitzgerald - MarketBeat
Is Pfizer (NYSE:PFE) Using Too Much Debt? - Yahoo Finance
Cwm LLC Raises Stake in Pfizer Inc. $PFE - MarketBeat
Sippican Capital Advisors Has $2.25 Million Stock Holdings in Pfizer Inc. $PFE - MarketBeat
Means Investment CO. Inc. Sells 22,379 Shares of Pfizer Inc. $PFE - MarketBeat
Callan Family Office LLC Purchases 48,269 Shares of Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. (NYSE: PFE) Price Prediction and Forecast 2025-2030 (October 2025) - 24/7 Wall St.
Pfizer (PFE) Faces Challenges Amid Drug Pricing Push - GuruFocus
LaRuby May and team of attorneys file suit against Pfizer, claim negligence in premature release of sickle cell drug therapy - AFRO American Newspapers
Precision Trading with Pfizer Inc. (PFE) Risk Zones - news.stocktradersdaily.com
Guggenheim Keeps Their Buy Rating on Pfizer (PFE) - The Globe and Mail
Pfizer Inc. $PFE Shares Bought by Fifth Third Wealth Advisors LLC - MarketBeat
Drucker Wealth 3.0 LLC Sells 15,443 Shares of Pfizer Inc. $PFE - MarketBeat
Aberdeen Group plc Increases Position in Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. | Pharmaceuticals, Vaccines & Company History | Britannica Money - Britannica
Pfizer (NYSE:PFE) Trading Down 1.7%What's Next? - MarketBeat
Pfizer (PFE) Target Price Lowered by Morgan Stanley | PFE Stock News - GuruFocus
Next medicine deal after Pfizer? Analysts, shares point to AstraZeneca, Eli Lilly - WHTC
FDA Gives Tentative Nod to Sandoz's Generic Version of Pfizer's Inlyta - GuruFocus
Sandoz granted tentative approval for generic of Pfizer's Inlyta - Seeking Alpha
Pfizer's Q3: The Catalyst For A Bullish Resurgence (Earnings Preview) (PFE) - Seeking Alpha
Dividend Roundup: Lockheed Martin, Pfizer, Genpact, Delta Air Lines, and more (SCHD:NYSEARCA) - Seeking Alpha
JB Capital LLC Reduces Position in Pfizer Inc. $PFE - MarketBeat
Saudi Arabia Adult Vaccine Market Forecast Report 2025-2033 Featuring Company Analysis and Vaccine Sales of GlaxoSmithKline, AstraZeneca, Sanofi Pasteur, Pfizer, CSL LimitedResearchAndMarkets.com - Business Wire
Commerzbank Aktiengesellschaft FI Purchases 83,531 Shares of Pfizer Inc. $PFE - MarketBeat
Morgan Stanley Adjusts Price Target on Pfizer to $32 From $33, Maintains Equalweight Rating - MarketScreener
Pfizer's Deal on Drug Prices Gets Closer to the Right Idea - Bloomberg.com
Pfizer Inc. $PFE Holdings Boosted by Coerente Capital Management - MarketBeat
Blair William & Co. IL Reduces Stock Holdings in Pfizer Inc. $PFE - MarketBeat
Vontobel Holding Ltd. Purchases 14,808 Shares of Pfizer Inc. $PFE - MarketBeat
First Merchants Corp Decreases Stock Holdings in Pfizer Inc. $PFE - MarketBeat
Maryland State Retirement & Pension System Buys 10,986 Shares of Pfizer Inc. $PFE - MarketBeat
Pfizer (NYSE:PFE) Shares Down 1.8%What's Next? - MarketBeat
Pfizer declares $0.43 dividend - MSN
Pfizer Declares Fourth-Quarter 2025 Dividend - BioSpace
Pfizer Inc Stock (PFE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.86%
0.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):